Financial Services Review | Monday, November 18, 2024
PÔNT, a top 10 global M&A advisory firm, is thrilled to present a rare ACQUISITION OPPORTUNITY WITH A MARKET-LEADING FLEET LEASING & CAR RENTAL COMPANY STRATEGICALLY LOCATED IN ONE OF LATAM'S MOST DYNAMIC ECONOMIES.
Fleet Leasing & Car Rental Market Leader with nearly 40,000 Vehicles under Management and trusted by a distinguished roster of private sector and government clients, this company is a recognized leader in fleet management and car rental services.
Prime Regional Access Positioned within a strategically connected market, this company benefits from seamless access to both North and South American markets and robust regional trade networks.
Stay ahead of the industry with exclusive feature stories on the top companies, expert insights and the latest news delivered straight to your inbox. Subscribe today.
With exceptional financial performance, impressive revenue, EBITDA, and a strong growth trajectory, this company is primed for continued expansion within a thriving consumer and industrial landscape.
Tailored, Proprietary State-of-the-Art Technology, and Copyright Proprietary Telematics Platform & Full Fleet Leasing Services: Leveraging advanced telematics and a full suite of fleet services, this company is poised to capture growing demand in one of LATAM's most promising markets, offering significant growth and scalability for investors.
This acquisition offers a unique opportunity as an entry point or synergy opportunity in a high-growth sector with substantial potential.
About PÔNT: We are a top 10 global M&A advisory firm specializing in connecting business owners with strategic international buyers and guiding clients through both buy-side and sell-side opportunities across diverse industries. Connect with PONT today to explore this outstanding opportunity further. Visit our website to learn more.
PÔNT, ASSOCIATES, LLC AWARDED MANDATE TO FACILITATE SALE OF BETA PHARMACEUTICALS, A LEADING MEXICAN HEALTHCARE COMPANY
Dallas, Texas — PÔNT, a top 10 global
M&A advisory firm is pleased to announce it has been awarded a mandate to facilitate the sale of BETA Pharmaceuticals, a well-established leader in Mexico's healthcare sector.
This opportunity provides strategic investors with seamless entry or expansion into a significant pharmaceutical market, according to Mark Camstra, Co-founder and VP of PÔNT.
For over 20 years, BETA Pharmaceuticals has been a trusted healthcare leader in Mexico, delivering essential medications like antibiotics, analgesics, and chronic disease treatments. Strong partnerships with providers and distributors ensure BETA's products reach communities nationwide.
"This is an exceptional chance to acquire a well-established company with growth potential," said Camstra. "PÔNT is thrilled to support BETA in this next chapter."
Strategic Partnerships: Raul Fabre, Co-founder and VP of PÔNT, noted BETA's deep industry ties. "BETA's trusted relationships make it a highly attractive acquisition target," he remarked.
Significant Growth Potential: Carlos Roberto Fabre, Creative and Investor Relations Director at PÔNT, emphasized the company's growth prospects. "BETA Pharmaceuticals has the capacity to expand internationally, positioning it as an ideal acquisition for buyers aiming to scale seamlessly throughout Latin America and beyond," Fabre explained.
Investment Highlights of BETA Pharmaceuticals
● A comprehensive range of diverse products addressing essential healthcare needs.
● Established partnerships with healthcare providers and distribution channels.
● Market Leadership: Recognized authority in Mexico's vibrant pharmaceutical industry.
● Growth Potential: Poised for expansion into international markets.
BETA Pharmaceuticals offers investors a rare chance to acquire a market leader with steady revenue and a legacy of success in Latin America's healthcare sector.
More in News